DEF: Faraday Future Seeks Stockholder Approval for Share Increase and Common Stock Issuance
Proxy Statement
Faraday Future is holding a special meeting on March 7, 2025, to seek stockholder approval for increasing authorized shares and issuing common stock to holders of convertible notes and warrants.
Summary
- Faraday Future is holding a Special Meeting of Stockholders on March 7, 2025, to vote on four proposals.
- Proposal 1 seeks approval to amend the company's charter to increase the authorized shares of common stock by 25,000,000, from 104,245,313 to 129,245,313.
- Proposal 2 seeks approval for the issuance of common stock to holders of certain convertible notes and warrants, in accordance with Nasdaq Listing Rule 5635(d).
- Proposal 3 is to ratify the selection of Macias Gini & O'Connell LLP as the independent registered public accounting firm for the year ending December 31, 2025.
- Proposal 4 seeks approval for one or more adjournments of the Special Meeting to permit further solicitation of proxies, if necessary.
- The Board of Directors recommends voting FOR each of the four proposals.
- The record date for determining stockholders eligible to vote is January 28, 2025.
- The meeting will be held virtually.
Sentiment
Score: 6
Explanation: The document is neutral in tone, presenting necessary information for a shareholder vote. The need for additional shares and financing suggests ongoing financial challenges, but the potential for future growth is also mentioned.
Positives
- Approval of the share authorization proposal would allow the company to meet its existing obligations to issue shares, obtain future financing, and meet the goals of its compensation strategy.
- The Board believes that the engagement of MGO as our independent auditors is in the best interests of FF and our stockholders.
Negatives
- The future issuance of additional shares of Class A Common Stock (other than by way of a stock split or dividend) would have the effect of diluting the voting rights and could have the effect of diluting earnings per share and book value per share of existing stockholders.
- If the Share Authorization Proposal is not approved at the Special Meeting, the Charter will not be amended to increase the number of authorized shares of Common Stock, by 25,000,000, from 104,245,313 to 129,245,313, increasing the total number of authorized shares of the Common Stock and Preferred Stock, by 25,000,000, from 114,245,313 to 139,245,313.
- The failure to obtain approval of the Share Authorization Proposal may hinder the Company from meeting its existing obligations to issue shares of Common Stock as and if they become due, from obtaining future financing and from meeting the goals of its compensation strategy.
Risks
- Failure to approve the share authorization proposal could hinder the company's ability to meet obligations, obtain financing, and execute its compensation strategy.
- The issuance of additional shares could dilute the voting rights and earnings per share of existing stockholders.
Future Outlook
FF expects that it may be able to raise additional capital to support the ramp-up of production of the FF 91 to potentially generate sufficient revenues to put the Company on a path to cash flow break-even.
Industry Context
The electric vehicle industry is capital-intensive, and companies often need to raise additional funds to support production and growth.
Stakeholder Impact
- Approval of the proposals could impact shareholders through potential dilution but also enable the company to secure necessary funding.
- Employees and other stakeholders could benefit from the company's ability to continue operations and execute its business plan.
Next Steps
- Stockholders need to vote on the proposals before the Special Meeting on March 7, 2025.
- The company will file the Charter amendment with the Secretary of State of Delaware promptly after the Special Meeting if the Share Authorization Proposal is approved.
Key Dates
| Date | Description |
|---|---|
| February 11, 2020 | Original Certificate of Incorporation filed |
| July 21, 2020 | Amended and Restated Certificate filed |
| July 21, 2021 | Second Amended and Restated Certificate filed |
| November 22, 2022 | Certificate of amendment to the Second Amended and Restated Certificate was filed |
| March 1, 2023 | Second certificate of amendment to the Second Amended and Restated Certificate was filed |
| June 16, 2023 | Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock was filed |
| August 4, 2023 | Initial Issuance Date of the Streeterville Notes |
| August 24, 2023 | Certificate of Elimination of Series A Preferred Stock was filed |
| August 24, 2023 | Third Amended and Restated Certificate filed |
| December 21, 2023 | Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock was filed |
| February 5, 2024 | Certificate of Elimination of Series A Preferred Stock was filed |
| February 5, 2024 | Certificate of amendment to the Third Amended and Restated Certificate was filed |
| February 23, 2024 | Second certificate of amendment to the Third Amended and Restated Certificate was filed |
| May 17, 2024 | Holders acquired the Streeterville Notes |
| June 21, 2024 | Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock was filed |
| July 31, 2024 | Information regarding the direct and indirect interests in the Company, by security holdings of FF Global, FF Top and the FF Top Representatives is included in the Company's Definitive Proxy Statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission (the SEC) |
| August 1, 2024 | Certificate of Elimination of Series A Preferred Stock was filed |
| August 1, 2024 | Third certificate of amendment to the Third Amended and Restated Certificate was filed |
| August 14, 2024 | Fourth certificate of amendment to the Third Amended and Restated Certificate was filed |
| August 29, 2024 | Company entered into an Exchange Agreement |
| September 5, 2024 | Company entered into a Securities Purchase Agreement |
| September 6, 2024 | The information set forth herein in connection with the September Financing is qualified in its entirety by reference to the full text of the form of the September Purchase Agreement, September Warrants, September Incremental Warrants, PA Warrants and Secured Notes attached as exhibits 10.1, 4.1, 4.2, 4.3, 4.4, respectively, to the Company's Current Report on Form 8-K, filed with the SEC |
| September 12, 2024 | Initial closing occurred |
| September 30, 2024 | Subsequent closing occurred |
| December 21, 2024 | Company entered into a Securities Purchase Agreement |
| December 23, 2024 | The information set forth herein in connection with the December Financing is qualified in its entirety by reference to the full text of the form of the December Purchase Agreement, December Warrants, December Incremental Warrants, and Unsecured Notes attached as exhibits 10.1, 4.1, 4.2, and 4.3, respectively, to the Company's Current Report on Form 8-K, filed with the SEC |
| December 31, 2024 | Initial closing occurred |
| January 17, 2025 | Second closing occurred |
| January 22, 2025 | Final closing occurred |
| January 28, 2025 | Record Date for the Special Meeting |
| January 28, 2025 | Company entered into a letter agreement |
| February 10, 2025 | This Notice of Special Meeting, the accompanying Proxy Statement and the form of proxy are first being mailed on or about February 10, 2025 to stockholders of record as of January 28, 2025 (the Record Date). |
| March 7, 2025 | Special Meeting of Stockholders |
Keywords
Faraday Future, share authorization, common stock, convertible notes, warrants, proxy statement, special meeting, financing, dilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.